Casandra
Casandra Test Code QD79449Version 1 (DRAFT)
Performing Lab
Aquaporin‑4 Antibody (IgG), CBA
Clinical Use
Order TestUse
Antibody to Aquaporin‑4 is associated with neuromyelitis optica (NMO), a demyelinating disease of the central nervous system that may resemble multiple sclerosis or transverse myelitis. Differentiating NMO from MS early is clinically important, as optimal treatment approaches differ significantly and early detection can guide appropriate therapy.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Aquaporin‑4
ProteinIgG Antibody • Other • Binary (Detected / Not Detected)
Result Turnaround Time
8 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.3 mL
Container
red‑top tube (no gel)
Causes for Rejection
Serum separator tube (SST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 21 days |
Related Tests
Other tests from different labs that may be relevant
Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF
ARUP Laboratories
Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum
ARUP Laboratories
Neuromyelitis Optica, IgG Autoantibodies
Labcorp
Anti-Aquaporin 4 (AQP4), Serum
Labcorp
Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Spinal Fluid
Mayo Clinic Lab
Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Serum
Mayo Clinic Lab
Aquaporin‑4 Receptor Antibody (Change effective as of 05/20/24: Refer to 2013320)
ARUP Laboratories
CNS Demyelinating Disease Evaluation Profile, Serum
Labcorp
Autoimmune CNS Demyelinating Disease Reflexive Panel
ARUP Laboratories
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF
ARUP Laboratories
